# Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

> **NCT00232739** · PHASE3 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 100 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** CYPHER Sirolimus-eluting Coronary Stent

## Key facts

- **NCT ID:** NCT00232739
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2004-11
- **Final completion:** 2009-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2010-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232739, "Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00232739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*